All Medicines
Dr. Aditya Singh

Medically Reviewed By

Dr. Aditya Singh, MBBS, MD (Pharmacology)

Reg No: MCI-654321 • Verified Medical Reviewer

Endocrine therapy

Inluriyo

(imlunestrant)

Uses, side effects, dosage information & price range

Eli Lilly Nederland B.V.

About this medicine

Inluriyo is indicated as monotherapy for the treatment of adult patients with oestrogen receptor (ER)-positive, HER2-negative, locally advanced or metastatic breast cancer with an activating ESR1-mutation, who have disease progression following prior treatment with an endocrine based regimen (for biomarker-based patient selection, see section 4.2).In pre- or perimenopausal women, or men, Inluriyo should be combined with a luteinising hormone-releasing hormone (LHRH) agonist.

Common Substitutes & Alternatives

These medicines share the same salt composition or therapeutic category and can be used as substitutes under professional medical supervision.

EtcamahComposition: camizestrantAstraZeneca AB
Price on RequestView Details →
CamceviComposition: leuprorelinAccord Healthcare S.L.U.
Price on RequestView Details →
ErleadaComposition: apalutamideJanssen-Cilag International NV
Price on RequestView Details →
XtandiComposition: enzalutamideAstellas Pharma Europe B.V.
Price on RequestView Details →
OrserduComposition: elacestrantStemline Therapeutics B.V.
Price on RequestView Details →

Key Information

Salt / Composition

imlunestrant

Category

Endocrine therapy

Manufacturer

Eli Lilly Nederland B.V.

Need a doctor's consultation?

Don't self-medicate. Consult a doctor before taking any medicine.

Medical Disclaimer

This information is for educational purposes only and is not a substitute for professional medical advice. Always consult your doctor or pharmacist before taking any medication. Prices are indicative and may vary. Do not start, stop, or change the dosage of any medicine without your doctor's approval.

Disclaimer:Content on this page is for informational purposes only. Do not consume prescription medication without a registered practitioner's direct oversight.